Overview Fundamentals API Earnings EOD API Sample Code Pricing

Kiora Pharmaceuticals Inc (KPRX NASDAQ) stock market data APIs

$4.62 -0.06(-1.3%) as of July 24, 2024
Price chart is built with Anychart

Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 2 clinical trials indicated for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. The company is also developing KIO-104, a non-steroidal, immuno-modulatory, small-molecule inhibitor of dihydroorotate dehydrogenase, currently under phase 1b/2a study for the treatment of posterior non-infectious uveitis, as well as under pre-clinical development for the treatment of proliferative vitreoretinopathy; KIO-101, an eye drop for the treatment of ocular presentation of rheumatoid arthritis; and KIO-201, an eye drop for treating patients undergoing photorefractive keratectomy (PRK) surgery for corneal wound repair. It has commercialization agreement with 4SC Discovery GmbH, for KIO-101; and collaboration agreement with Théa Open Innovation for the development KIO-301. The company was formerly known as Eyegate Pharmaceuticals, Inc. and changed its name to Kiora Pharmaceuticals, Inc. in November 2021. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Encinitas, California.

Kiora Pharmaceuticals Inc Financial Data Overview

13 653 K
2 917 K
16 000 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'KPRX',
Type: 'Common Stock',
Name: 'Kiora Pharmaceuticals Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG0083Y1PH9',
CIK: '1372514',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2015-07-31',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,

Kiora Pharmaceuticals Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 16 000 K
  • EBITDA 6 274 K
  • Earnings Per Share -11.79
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Kiora Pharmaceuticals Inc Earnings via APIs

  • Latest Release 2024-05-10
  • EPS/Forecast -0.07

Get Kiora Pharmaceuticals Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?